Somewhere right now, a woman is sitting in a doctor's office being told her pain is normal. She has heard it before. She will hear it again.

The average diagnostic journey for endometriosis takes 7 to 10 years. Not because the disease is rare. Because research funding has never matched the scale of the problem. NIH allocates $2 per patient per year to endometriosis research. For a condition affecting 1 in 10 women, that number reflects decades of misplaced priorities.

Veridyn is building that test. The Research phase is complete. Findings met our pre-specified criteria. What comes next requires real patient samples, a certified research facility to process them, and the rigorous data analysis that determines which biological signals hold up under scrutiny and which do not. That is what this campaign funds.

---

Pilot phase goal

$55,000

This campaign funds the first feasibility experiments, the minimum necessary to establish whether a meaningful biological signal can be detected. Veridyn has already completed rigorous analysis of publicly available biological data, establishing the scientific basis for this approach. Community-funded preliminary data does not just advance the science. It is what would give Veridyn a competitive edge when applying for the limited formal research funding that does exist.

Your dollar closes that gap.